Today, Novo Nordisk announced new phase 3 interim data from its guardianTM2 trial for its recombinant coagulation factor VIII (rFVIII) product NovoEight® (turoctocog alfa), the first new rFVIII molecule in over a decade, which shows that it provides long-term reduction from bleeding in people with haemophilia A when used as a preventative treatment.1 The results were presented at the World Federation of Haemophilia (WFH) World Congress and support findings from other studies within the guardianTM clinical programme that found NovoEight® demonstrated good efficacy in preventing and treating bleeds without inhibitor development in previously treated patients.
To view the Multimedia News Release, go to: http://www.multivu.com/mnr/71400529-novoeight-reduction-of-bleeding-haemophilia-a
Syneron Medical Ltd. (NASDAQ:ELOS), a leading global aesthetic device company, announced today the international launch of the new PicoWay™ picosecond device at the 23rd European Academy of Dermatology and Venereology (EADV) Congress in Amsterdam, The Netherlands, October 8-12, 2014. PicoWay is a state-of-the-art dual wavelength device, with 532nm and 1064nm wavelengths, which utilizes proprietary PicoWay technology to generate picosecond pulses for the treatment of pigmented lesions and tattoos, including recalcitrant tattoos. The staged launch of PicoWay begins in the international market during October 2014 and will continue in the United States in the first half of 2015.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/72762556-syneron-launch-picoway-picosecond/
Data presented today at the World Diabetes Congress of the International Diabetes Federation (IDF) show that adults with type 2 diabetes achieved improved glycaemic control, significantly lower rates of overall and nocturnal confirmed hypoglycaemia for the full trial period, and a significantly lower rate of severe hypoglycaemia during the maintenance period (defined as week 16 onwards) with Ryzodeg® compared to biphasic insulin aspart 30, both administered twice-daily1.
Ryzodeg® is the first combination of two distinct insulin analogues, Tresiba® (insulin degludec), the once-daily basal insulin with an ultra-long duration of action, and the well-established mealtime insulin NovoRapid® (insulin aspart), in the ratio of 70% and 30%, in one pen for people with type 2 diabetes2-4.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/64158-ryzodeg-improved-glycaemic-control
Apothic Wines, known for their bold, intense blended wines that combine Old World intrigue with New World sophistication, is excited to announce the return of Apothic Dark. Its secret blend highlights unique and uncommon grapes to create a mysterious wine that is evocative of the romance found in darkness. This red wine blends dark fruit flavors of blueberry and blackberry with opulent notes of coffee and dark chocolate for a rich, yet silky smooth, wine experience.
To celebrate the return of Apothic Dark, Apothic Wine is convincing the world to “Go Dark” with its #GoDark campaign. The #GoDark promotion kicked off on September 24 when an impromptu dark parade descended on downtown Austin. Onlookers helping to “Keep Austin Dark” joined more than 50 mysteriously cloaked performance artists and Apothic enthusiasts in a procession that originated from Congress Bridge and culminated with dark revelry at a historic downtown theater.
To view the multimedia release go to:
http://www.multivu.com/players/English/7617151-apothic-wine-godark/
Federally funded research that provides a deep understanding of cancer is spurring advances against many types of the disease. With a strong bipartisan commitment from Congress to keep investment in biomedical research a national priority, we can accelerate our pace of progress and save more lives from cancer, according to the seventh annual American Association for Cancer Research (AACR) Cancer Progress Report, released today.
Basic research in the fields of immunology and cancer genetics has recently been harnessed to develop two new forms of cancer treatment: immunotherapy and precision medicine. As detailed in the report, the utility of these treatments is expanding rapidly. In May 2017, the U.S. Food and Drug Administration (FDA) heralded a new dawn for precision medicine when it approved the immunotherapeutic pembrolizumab (Keytruda) for treating patients with any solid tumor harboring specific genetic characteristics. This is the first anticancer therapeutic approved based on cancer biomarkers rather than the location in the body where the cancer originated.
To view the multimedia release go to:
https://www.multivu.com/players/English/8155051-aacr-cancer-progress-report-2017/
The foetus moves its mouth in an exaggerated manner when it hears a human voice. This occurs from the 16th week of pregnancy (with a foetus of 11cm) and only when the voice reaches it through an intravaginal device developed for this purpose. This is one of the conclusions of the study presented by Dr. Álex García-Faura, the Scientific Director of the Institut Marquès, at the 25th European Congress of Perinatal Medicine held in Maastricht (Netherlands).
The study finds that babies hear practically no external noise and only react when sound reaches them through the vagina, which confirms that they hardly hear voices through the mother’s abdomen. Their reactions were studied using Babypod®, a small device that is inserted into the vagina like a tampon and is connected to a mobile phone, enabling the voice of the mother or anyone else to reach the foetus.
To view the multimedia release go to:
http://www.multivu.com/players/uk/7859951-institut-marques-babies-react-mother-voice/
The International Nut and Dried Fruit Council (INC) has celebrated the XXXV World Nut and Dried Fruit Congress in San Diego. From May 30th until today, more than 1,400 delegates have participated in the only and largest international event dedicated to the nut and dried fruit industry that this year’s edition has broken previous records of attendance.
The INC Congress featured a stimulating three-day program to exchange knowledge, ideas and experiences. Attendees had over 16 sessions, among round tables, seminars and keynote speakers’ presentations ranging in topics from market dynamics, crops and production forecasts, agricultural and water resources, new findings in health and nutrition, and product innovations.
Steve Junqueiro, Co-president and COO of Save Mart Supermarkets, shared his vision on the future of American supermarkets. He outlined a market featured by a more digital consumer driven by food transparency, convenience, connectivity, emotional connection and local and sustainable supply.
To view the multimedia release go to:
http://www.multivu.com/players/uk/7849351-inc-world-nut-dried-fruit-congress/
In the U.S., approximately 159,000 women are living with metastatic breast cancer. To raise awareness of Metastatic Breast Cancer Awareness Day on October 13, MedImmune Specialty Care Division of AstraZeneca (NYSE: AZN) is launching the My+Story online resource center, which highlights the needs of women living with metastatic breast cancer and calls attention to metastatic disease as a key component of October’s National Breast Cancer Awareness Month. Metastatic Breast Cancer Awareness Day was officially recognized by the U.S. Congress in 2009, following a grassroots awareness effort led by members of the Metastatic Breast Cancer Network (MBCN).
To view Multimedia News Release, go to http://www.multivu.com/mnr/63080-astrazeneca-metastatic-breast-cancer-awareness
Results from the global Diabetes Attitudes, Wishes and Needs 2 study (DAWN2™) presented today at a symposium during the World Diabetes Congress of the International Diabetes Federation (IDF), show that only 29% of people with diabetes report that their healthcare team ask for their input when making their treatment plans. Furthermore, only 33% said they were encouraged by their healthcare professional to ask questions in the consultation.
To view Multimedia News Release, go to http://www.multivu.com/mnr/64152-novo-nordisk-diabetes-report-doctor-treatment
The full set of data from EUCLID, the largest ever prevalence study of Clostridium difficile infection (CDI) across Europe, were presented today at the 24th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID). Data from 482 European hospitals reveal that in a single day, an average of 109 cases of CDI are missed due to a lack of clinical suspicion or inadequate laboratory testing, potentially leading to more than 39,000 missed cases in Europe each year.
To view the Multimedia News Release, go to: http://www.multivu.com/mnr/71400524-EUCLID-clostridium-difficile-infection
Mexico has seen rapid growth in its meetings industry, reporting a 10.4% increase of business in the first two months of the year when compared to the same period in 2016, announced the Mexico Tourism Board. According to the International Association of Congresses and Conventions (ICCA), Mexico now ranks 5th in the Americas in terms of the number of hosted events, which have now reached 182 world congresses and more than 300,000 meetings in 2016. These numbers are a direct result of Mexico’s global initiative to position and promote Mexico as Latin America’s leader in the world congress arena.
“Our world-class conference facilities, accommodations, and welcoming community are the drivers behind Mexico's continued growth and its recognition as a top global industry player in the meetings and events space,” remarked Hector Flores, CEO of the Mexico Tourism Board. “Additionally, Mexico's strong commitment to increasing air connectivity allows us to facilitate travel from all corners of the world.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8128751-mexico-tourism-meetings-conferences/
Last night Boys & Girls Clubs of America (BGCA) named Whitney Stewart National Youth of the Year in a ceremony held at the National Building Museum in Washington D.C. She accepted the honor before an audience that included members of Congress and Boys & Girls Clubs of America (BGCA) partners and supporters, including National Spokesperson and Club alum Denzel Washington.
Youth of the Year is BGCA's premier recognition program for Club teens and the National Youth of the Year title is the highest honor a Club member can receive, representing the voice of four million Club youth. For nearly 70 years, the Youth of the Year program has recognized young people for their outstanding leadership, service, academic excellence and dedication to living a healthy lifestyle. The Youth of the Year program is presented by Disney with support from signature partner Toyota. Along with additional partners Taco Bell Foundation and University of Phoenix, the National Youth of the Year will receive $145,000 in academic scholarships, as well as a trip to Disney World and a brand new Toyota vehicle. This year Youth of the Year will award more than $1 million in scholarships to Club teens.
To view the multimedia release go to:
http://www.multivu.com/players/English/7640151-bgca-national-youth-of-the-year/
Boys, Girls, Clubs, America, Youth of the Year, Denzel Washington, program, Disney, children, mentor, MultiVu, MultiVu 7640151
